Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Saccharomyces boulardii and Improved Feeding Tolerance

Doses used in studies

mg/kg/day: 50 (median 50, IQR 50–50) — 1 study

Safety in these studies

Overall tolerabilityReported
Saccharomyces boulardii is one of the best-studied probiotics in acute gastroenteritis (AGE) and is shown to be safe
from: Saccharomyces boulardii CNCM I-745 in different clinical conditions.

1 of 1 paper

Saccharomyces boulardii CNCM I-745 in different clinical conditions.
- 2014-07-04
- Review
- Expert opinion on biological therapy 14(11)
- - Ener Cagri Dinleyici
  - Ates Kara
  - Metehan Ozen
  - Yvan Vandenplas
- PubMed: 24995675
- DOI: 10.1517/14712598.2014.937419
8 Insights on
- Improved Feeding Tolerance
- Low evidence
There are new promising results (improving feeding tolerance, shorten the course of hyperbilirubinemia)
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
not specified